Companion Diagnostics News on companion diagnostics and drug/test co-development. Ikonisys Launches Next Generation of CTC Detection, Analysis Platform; Expands US Presence Premium Proceeds from a recent European public offering will fund commercialization of the French company's Ikoniscope20 platform in the US and EU. Merck, Burning Rock Ink Liquid Biopsy Companion Diagnostics Deal The companies intend to develop Burning Rock's 168-gene OncoCompass Target test as a companion to Merck's MET inhibitor Tepmetko in mainland China. Sysmex Inostics Sees Ultra-Sensitive Leukemia Liquid Biopsy as Potential CDx Premium Sysmex also recently formed a companion diagnostic development partnership with Qiagen, which could help with its efforts in this area. I-Mab, Roche Diagnostics to Codevelop Companion Diagnostics in China Under the collaboration, I-Mab and Roche will jointly develop companion diagnostics for I-Mab's assets under development. Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing The companies will provide help with clinical drug trials and companion diagnostics projects that need a China arm for global or China-focused trials. Nov 4, 2021 Burning Rock, Impact Therapeutics Ink Testing Deal for ATR Inhibitor Oct 11, 2021 EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access Premium Sep 16, 2021 FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC Sep 10, 2021 Japanese Health Ministry Clears Thermo Fisher Scientific Oncomine Assay as CDx for Lung Cancer Drug Sep 7, 2021 Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay Sep 1, 2021 Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs Aug 26, 2021 FDA Clears Thermo Fisher Scientific Oncomine Assay as CDx for Bile Duct Cancer Drug Aug 19, 2021 Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan Aug 17, 2021 Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko Aug 9, 2021 Qiagen, OncXerna Therapeutics Ink Companion Dx Development, Technology-Licensing Deal Aug 5, 2021 State-Regulated Illinois Health Plans Subject to Biomarker Test Coverage Mandate Starting 2022 Premium Aug 5, 2021 Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug Aug 3, 2021 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib Jul 16, 2021 FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC Jul 1, 2021 FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor Jul 1, 2021 Qiagen, Sysmex Form Global Companion Diagnostic Development Pact Jun 30, 2021 AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies Jun 15, 2021 Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development May 28, 2021 FDA Approves Bile Duct Cancer Drug from Helsinn, BridgeBio Pharma With Foundation Medicine CDx May 28, 2021 FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen Load More Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.